The extracellular portion of the insulin receptor b-subunit regulates the cellular trafficking of the insulin -insulin receptor complex. Studies on Chinese hamster ovary cells carrying the Cys 860 ! Ser insulin receptor mutation 
Introduction
Upon insulin binding with the specific membrane receptor (IR) (1), the insulin -IR complex is internalized (2, 3) . It has been suggested that this process contributes to modulation of insulin action by regulating IR number (4) . Once internalized, the IR can undergo subcellular compartmentalization (5) , but the vast majority is returned to plasma membrane via a recycling pathway (6) . IR internalization and down-regulation require the coordinated action of several cellular mechanisms (7 -9) . The IR transmembrane region and flanking amino acids seem to play a key role (7) . Moreover, internalization motifs have been identified in the juxtamembrane cytoplasmic domain (9) . Finally, IR tyrosine kinase activity is required for the endocytosis of the insulin -IR complex (10) .
The extracellular domain of IR b-subunit regulates the b-subunit phosphorylation (11) . Transfection of Chinese hamster ovary (CHO) cells with human engineered IR cDNA to mutate Cys 860 to Ser (CHO-IR C860S ) in the extracellular domain of IR b-subunit reduces insulin internalization (12) , as well as insulin receptor substrate (IRS)-1 tyrosine phosphorylation, but not Shc phosphorylation (13) . These actions are associated with a reduction in insulin-induced metabolic and mitogenic effects. These findings indicate a function of the extracellular domain of IR b-subunit in insulin signaling and IR intracellular compartmentalization.
Here, we have determined in more detail the role of C860S in the intracellular targeting of the insulin -IR complex and in the regulation of insulin degradation and retroendocytosis.
Materials and methods
Mutagenesis of cysteine 860 with serine in the extracellular portion of IR b-subunit
Mutation of cysteine 860 with serine was performed as previously described (12) . Briefly, a pCMV-HIR plasmid was used as template (12) . PCR reactions were carried out to give two fragments of 918 and 1949 bp respectively, using the following primers: A, 5
0 . The intermediate products were hybridized together and used as a template for a further amplification using primers A and D. After digestion with Bsm1 and Afl2, the resulting DNA fragment was bound into pCMV-HIR plasmid, replacing the corresponding Bsm1-Alf2 wild type (WT) sequence. The entire DNA fragment produced by PCR was then sequenced by deoxy sequencing to confirm the absence of other mutations.
Cell culture and transfection
Chinese hamster ovary cells (CHOK1), grown in DMEM medium with 10% fetal calf serum, were stably transfected with IR C860S and screened for high level of expression by A14-125 I-insulin binding. A clonal cell line was obtained as previously described (12) . The generation of the CHO cell line CHO-IR WT has been described previously (12) .
For the purpose of the study, cells were grown to subconfluence and serum-starved in F12 medium with 0.5% BSA for 16 -24 h before each experiment.
Insulin receptor internalization and insulin receptor recycling
In order to reach maximal receptor internalization, cells expressing WT or mutated IR were incubated in Hepes buffer (50 mmol/l Hepes; 120 mmol/l NaCl; 1 mmol/l MgSO 4 ; 5 mmol/l KCl; 1 mmol/l CaCl 2 and 1% BSA; pH 7.8) at 37 8C for different time periods in the presence of 100 nmol/l unlabeled insulin. At the end of each incubation period, insulin bound to surface receptors was removed by acid (pH 4.5) wash (14) . Insulin binding was measured before and at different times after cell exposure to unlabeled insulin. IR internalization studies were also repeated in the absence of insulin after 60-min incubation with 50 mmol/l monensin (Sigma, St Louis, MO, USA) at 37 8C. Monensin traps internalized IR in the intracellular compartment, allowing measurement of constitutive IR internalization (15) . Insulin receptor recycling was evaluated after maximal receptor internalization by reincubating cells at 37 8C in an insulin-free medium to allow internalized receptor to return to the cell surface. Insulin binding was measured when maximal internalization was reached (time 0) and at 30, 60 and 90 min during rewarming. For insulin receptor binding measurement, cells were incubated with HPLC purified A14-125 I-insulin (34 pmol/l) (16) in Hepes buffer (pH 7.8) at 16 8C for 180 min. Then, cells were extensively washed with cold PBS and solubilized with 0.4 mol/l NaOH, before counting on a g-counter (Packard Instrument, Dowers Grove, IL, USA).
Dissociation of the insulin receptor complex
After 60-min incubation with A14-125 I-insulin at 37 8C, cells were either washed 3 times with both cold PBS and acid solution (14) or washed and reincubated for different time periods at 37 8C in an insulin-free medium. At the end of each time period, cells were scraped and solubilized for 30 min in cold 0.5% Triton X-100, in order not to disrupt the insulin-receptor complexes (17, 18) , in 25 mmol/l Hepes buffer (pH 7.5) containing 0.1 mg/ml aprotinin. One aliquot of the solubilized cells was then counted for measurement of total cell associated radioactivity, while a second aliquot was combined with 350 ml 1% g-globulin in PBS and 700 ml 25% polyethylene glycol (PEG). The aliquot was then centrifuged in a microfuge at 4 8C for 5 min. The supernatant was removed and the radioactivity in the pellet counted and corrected for unspecific insulin precipitation (, 2%).
Assessment of IR dephosphorylation
Cells were grown to subconfluence and serum-starved in DMEM (Sigma Chemical Co., St. Louis, MO, USA) for 12 h before the experiments. Phosphorylation of the b-subunit of IR was obtained by cell incubation with 10 nmol/l insulin for 10 min at 37 8C. For dephosphorylation assessment, cells were acid washed to remove insulin bound to surface receptors, and resuspended in Hepes buffer at 37 8C. To evaluate phosphorylation, cells were washed with cold PBS and then 500 ml lysis solution (50 ml of 150 mmol/l Tris, pH 6.8, 6.9% SDS, 30% glycerol, and 100 mmol/l dithiothreitol, heated at 100 8C for 2 min) were added. Lysed cells were centrifuged at 15 000 g for 40 min and the supernatant immunoprecipitated with anti-IR antibody (Upstate Biotechnology, Lake Placid, NY, USA) for 14 h at 4 8C. Protein A-Sepharose was then added and the incubation continued for a further 90 min. Sepharose-bound immunocomplexes were washed with the lysis buffer and boiled for 5 min in Laemmli sample buffer. Samples were then resuspended in 7.5% SDS-PAGE for electrophoresis analysis. The separated proteins were transferred to nitrocellulose mem-branes using appropriate buffer (20 mmol/l Tris, 150 mmol/l glycine, 20% methanol, 0.02% SDS) for 1 h at 150 mA. Nitrocellulose filters were blocked in PBS, 0.1% Tween 20 and 5% BSA for 1 h at room temperature. Filters were then incubated with anti-IR antibody or with anti-phosphotyrosine antibody (Transduction Laboratories, Lexington, KY, USA) for 2 h at room temperature (13) . After final washing in PBS 0.1% Tween 20, bound antibodies were detected by enhanced chemiluminescence reagents according to the manufacturer's instructions (ECL; Amersham Pharmacia Biotech, Little Chalfont, Bucks, UK). The bands were quantified by a GS-690 Bio-Rad Densitometer with Multi Analyst-PS Software for image analysis (Dc Protein Assay; Bio-Rad Laboratories, Hercules, CA, USA). All results were normalized for mg/protein.
Insulin degradation
CHO cells expressing wild-type or IR C860S were incubated at 37 8C in Hepes buffer with 6.7 nmol/l A14-125 I-insulin in the presence or absence of 16.6 mmol/l unlabeled insulin for 60 min. At the end of the incubation period, the medium was removed, the cells were washed with cold PBS and incubated in Hepes buffer (pH 3.5) for 10 min at 4 8C. Cells were then scraped and suspended in ice-cold 0.25 mol/l sucrose, 5 mmol/l Tris, 8 mg/ml aprotinin, 2 mmol/l phenylmethylsulfonyl fluoride, 2 mmol/l orthovanadate (pH 7.4) and homogenized on a Dounce homogenizer (Kontes Glass Co., Vineland, NJ, USA). Nuclei and mitochondria were removed by centrifugation at 5000 g for 3 min at 4 8C and vesicles were collected from the supernatant by centrifugation at 40 000 g for 10 min (Kontron Instruments T-2070, Zurich, Switzerland). Endosomes were separated from lysosomes by centrifugation at 40 000 g for 1 h at 4 8C through self-forming Percoll gradient (starting density 1.07 g/ml). Fractions containing the endosomal vesicles were then pooled and the Percoll was removed by centrifugation at 100 000 g for 30 min at 4 8C. To determine endosomal radioactivity, the endosome fraction was solubilized with 0.1% Triton X-100 and 3 mol/l acetic acid for 1 h at 4 8C and was centrifuged in a microfuge for 30 min at 20 000 g at 4 8C. Labeled intact insulin in the endosomal fraction was finally determined by HPLC analysis using a Waters C18 m Bondapack (average particle size 10 mm) column (300 £ 3.9 mm I.D.) (Waters Associated, Milford, MA, USA) with 0.001 mol/l sodium phosphate buffer-isopropanolacetonitrile (68:11:21 v/v/v) containing 0.15 mol/l ammonium acetate and adjusted to pH 3.0 by hydrochloric acid as the mobile phase (19) .
Insulin retroendocytosis
In order to measure the release of intact A14-125 I-insulin from the intracellular compartment to medium, CHO cells overexpressing IR WT or IR
C860S
, after incubation with 6.7 nmol/l labeled insulin for 30 min at 37 8C to obtain maximal IR internalization, were acid washed to remove insulin bound to surface receptors and were then resuspended in insulin-free Hepes buffer at 37 8C. Aliquots of the incubation medium were then collected at given times for HPLC determination of intact insulin (19) .
Statistical analysis
All the results are expressed as means^S.D. of three experiments performed in triplicate. Statistical significance was assessed using a two-way analysis of variance (ANOVA) performed by StatView II (SAS Institute Inc., Cary, NC, USA).
Results

IR internalization
As previously reported, C860S substitution does not affect insulin receptor binding affinity either in vivo or in vitro (12) suggesting that Cys860 is not essential for insulin binding. As shown in Fig. 1 , after 30 min incubation with labeled insulin at 37 8C, IR internalization reached a plateau in both CHO-IR WT and CHO-IR C860S cells. However, in these latter cells the residual insulin binding was significantly higher compared with CHO-IR WT cells ð88^3% vs 67^8%; P , 0:01). The defect in receptor internalization in CHO-IR C860S cells was not dependent on insulin availability in the medium, since similar results occurred also after incubation with monensin. These results show that C860S substitution reduces both insulin induced and constitutive IR internalization.
Insulin-IR complex dissociation, IR dephosphorylation and recycling
After insulin -IR complex internalization, IR dissociates from insulin in the endosome (14) . This step is critical for further sorting and trafficking of insulin and IR (2). After maximal IR internalization, acid washing was associated with similar values of intracellular PEGprecipitable radioactivity in both solubilized cell lines (38^8% and 44^7% in CHO-IR WT and CHO-IR C860S cells respectively). Percentage decremental change from baseline of PEG-precipitable radioactivity is illustrated in Fig. 2 , showing a comparable time course and half life (t 1/2 ) of the dissociation process in the two cell lines. We then measured the rate of IR dephosphorylation in the intracellular compartment. Upon insulin incubation, phosphorylation of the IR b-subunit was superimposable in CHO-IR WT and CHO-IR C860S cells (Fig. 3A, time 0) . Cell reincubation in an insulin-free medium was associated with IR b-subunit dephosphorylation in both cell lines. Nonetheless, the rate of the dephosphorylation process was much more rapid and was greater in CHO-IR WT than in CHO-IR C860S cells (P , 0:01; Fig. 3B ).
After maximal internalization, IR was allowed to recycle to plasma membrane by reincubating cells at 37 8C in an insulin-free buffer and the recovery of insulin binding was measured at different times. The recycling of IR from intracellular compartment to plasma membrane was much faster for mutated (t 1/2 21 min) than for WT (t 1/2 40 min, P , 0; 001; Fig. 4) receptors. Moreover, the recovery of baseline insulin binding after 90 min rewarming was slightly but significantly lower in CHO-IR WT compared with CHO-IR C860S cells ð90^6 vs 98^1%; P , 0:01Þ:
Insulin degradation and retroendocytosis
Following internalization, insulin is then either degraded in the intracellular compartment or released undegraded into the extracellular medium (retroendocytosis) (2) . To study intracellular insulin degradation, cells were incubated with A14-125 I-insulin at 37 8C for To evaluate insulin retroendocytosis, cells were allowed to internalize insulin, were then acid washed and resuspended for different times at 37 8C in an insulin-free medium and intact insulin released into the medium was assessed by HPLC. As shown in Fig. 5 the ratio of intact insulin to total radioactivity (intact insulin plus degradation products) extruded from cells into the medium, was similar between CHO-IR WT and CHO-IR C860S cells. Moreover, the time course of insulin retroendocytosis was similar in the two cell types.
Discussion
Insulin receptor internalization and recycling is a physiological phenomenon, very likely associated with insulin signaling modulation (20) . Defects of the internalization and recycling of the insulin -IR complex have been described in conditions associated with insulin resistance, such as Type 2 diabetes (21) and obesity (22) . Moreover, insulin sensitizer agents, like metformin, improve insulin sensitivity and restore insulin-IR complex internalization and trafficking (22) . Therefore, unraveling the factors controlling insulin-IR complex trafficking may provide useful insight into the multiple pathogenetic mechanisms involved in insulin resistance. Among the various factors regulating this fine process, the intracellular and transmembrane portion of IR b-subunit have been shown to play a role (23 -26) . On the other hand, it has previously been shown that the extracellular domain of IR b-subunit regulates IR targeting (12) . In particular, C860S substitution impairs the lateral translocation of the insulin -IR complex on the cell surface, prevents IR down-regulation and causes, in CHO cells, a condition of insulin resistance by impairing IRS-1 tyrosine phosphorylation without affecting IR autophosphorylation (12, 13) .
Here we provide clear cut evidence that the C860S mutation in the IR b-subunit causes an impairment of insulin-induced IR internalization in spite of normal activation of IR autophosphorylation. Previously published data (12) have shown that C860S mutation does not affect insulin receptor binding affinity either in vivo or in vitro. These data rule out the possibility that the differences observed are due to altered kinetics of insulin binding and sensitivity in CHO-IR C860S compared with CHO-IR WT cells. Moreover constitutive internalization of the IR determined in the presence of monensin which prevents endosome acidification, was found to be reduced in the CHO-IR C860S cells (27 -29) . C860S substitution does not affect the rate of insulin -IR complex dissociation, insulin retroendocytosis and degradation which are similar in both cell types. This result is at variance with those of Yamada et al. (30) . In their hands, insulin degradation in wild type cells was 24%, with a slight reduction in CHO cells expressing human receptors mutated in their extracellular domain. A major difference, however, between their study and the present one resides in the methodology used for determination of insulin degradation. While we used an HPLC technique for separation of degraded insulin, in Yamada's study the trichloroacetic acid precipitation was employed, a technique which is known to overestimate insulin degradation (30) . Although insulin -IR complex dissociation and insulin degradation do not seem to be affected by the C860S mutation, the insulin receptor recycling appears to be faster and more extensive for mutated receptor. Since dissociation and degradation occur at the endosomal level upon acidification, the main effect of the mutation seems to be exerted at post-endosomal steps. Another step that does not seem to be affected in CHO-IR C860S cells is insulin retroendocytosis, suggesting that recycling of the IR and retroendocytosis of insulin occur via independent mechanisms. This observation is in full agreement with both biochemical (26) and morphological (31) studies showing that the receptor and its ligand physically segregate and move in separate vesicular structures. Moreover, since a backward transport of intact insulin -IR complex is unlikely, our estimate of insulin receptor recycling cannot be underestimated.
In spite of faster and more complete recycling of the mutated IR, its rate of dephosphorylation was lower when compared with the wild type IR. The nature of this difference is not readily apparent. Because the internalization of the mutated receptor is impaired, one could argue that the reduction of dephosphorylation is due to its predominant localization on the plasma membrane during insulin stimulation. The low fraction of mutated insulin receptor presented to specific intracellular phosphatases could then account for low dephosphorylation. However, this view is not supported by current knowledge that the dephosphorylation of activated IR occurs both on the plasma membrane and within the intracellular compartment. In intact cells, surface localized insulin receptors are dephosphorylated by a specific transmembrane protein tyrosine phosphatase (PTPa) (32) . An impairment of IR C860S dephosphorylation by PTPa seems unlikely as both IR and PTPa segregate in the same microenvironment and there are no data to support a decreased sensitivity of the mutated receptor to PTPa. In fact, we have already shown that C860S mutation does not modify insulin binding, b-subunit IR autophosphorylation, b-subunit and IRS-1 association (12) . On the other hand, after the endosomal dissociation of insulin, IR is rapidly dephosphorylated (33, 34) . The intracellular activation of a protein tyrosine phosphatase (PTP-1B) (35) has a major role in the negative regulation of insulin signaling. Thus, the abnormal intracellular routing of IR C860S may affect its potential association with PTP-1B (or other intracellular phosphatases) in various sub-cellular compartments. If we accept this hypothesis, we might conclude that C860S mutation accounts for an intracellular recycling of the insulin receptor that, in part, occurs via a non-dephosphorylating pathway.
In conclusion, Cys 860 in the IR b-subunit ectodomain regulates the early steps of IR intracellular targeting. C860 substitution redirects IR intracellular compartmentalization reducing the interaction with tyrosine phosphatases and increasing the recycling of mutated receptor, independently from insulin.
